| SC 13G | 2022-08-15 | INTRACOASTAL CAPITAL, LLC | Timber Pharmaceuticals, Inc. | 5,763,596 | 4.2% | EDGAR |
| SC 13G/A | 2022-02-14 | Altium Capital Management LP | Timber Pharmaceuticals, Inc. | 2,539,063 | 5.0% | EDGAR |
| SC 13G/A | 2022-02-04 | Hudson Bay Capital Management LP | Timber Pharmaceuticals, Inc. | 2,574,834 | 3.9% | EDGAR |
| SC 13G/A | 2022-01-18 | Empery Asset Management, LP | Timber Pharmaceuticals, Inc. | 9,866,540 | 5.0% | EDGAR |
| SC 13D/A | 2021-09-09 | TardiMed Sciences LLC | Timber Pharmaceuticals, Inc. | 3,308,567 | 9.0% | EDGAR |
| SC 13D/A | 2021-09-01 | TardiMed Sciences LLC | Timber Pharmaceuticals, Inc. | 3,733,567 | 10.2% | EDGAR |
| SC 13D/A | 2021-08-27 | TardiMed Sciences LLC | Timber Pharmaceuticals, Inc. | 4,134,067 | 11.3% | EDGAR |
| SC 13D/A | 2021-06-11 | TardiMed Sciences LLC | Timber Pharmaceuticals, Inc. | 4,783,982 | 13.0% | EDGAR |
| SC 13G/A | 2021-02-16 | Altium Capital Management LP | Timber Pharmaceuticals, Inc. | 206,875 | 10.0% | EDGAR |
| SC 13G | 2021-02-11 | Hudson Bay Capital Management LP | Timber Pharmaceuticals, Inc. | 1,335,447 | 10.0% | EDGAR |
| SC 13G/A | 2021-01-28 | Empery Asset Management, LP | Timber Pharmaceuticals, Inc. | 1,047,364 | 10.0% | EDGAR |
| SC 13D/A | 2020-09-24 | TardiMed Sciences LLC | Timber Pharmaceuticals, Inc. | 5,437,517 | 45.2% | EDGAR |
| SC 13G | 2020-05-29 | Altium Capital Management LP | Timber Pharmaceuticals, Inc. | 1,185,605 | 9.9% | EDGAR |
| SC 13D/A | 2020-05-28 | TardiMed Sciences LLC | Timber Pharmaceuticals, Inc. | 5,666,152 | 47.7% | EDGAR |
| SC 13G | 2020-05-27 | Empery Asset Management, LP | Timber Pharmaceuticals, Inc. | 1,126,325 | 9.5% | EDGAR |
| SC 13G/A | 2020-02-13 | Vivo Capital VIII, LLC | BioPharmX Corp | 539,926 | 3.4% | EDGAR |
| SC 13D | 2020-01-30 | Timber Pharmaceuticals LLC | BioPharmX Corp | 2,255,336 | 12.9% | EDGAR |
| SC 13G/A | 2020-01-15 | Empery Asset Management, LP | BioPharmX Corp | 988,224 | 5.0% | EDGAR |
| SC 13G/A | 2019-06-27 | Vivo Capital VIII, LLC | BioPharmX Corp | 857,196 | 7.6% | EDGAR |
| SC 13G/A | 2019-02-14 | Vivo Capital VIII, LLC | BioPharmX Corp | 29,626,684 | 13.9% | EDGAR |